Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   174,790    

Indirect Shares

  417,826      
Direct Value   $6,163,557    

Indirect Value

  $16,623,289      
Total Shares   592,616      
Total Value   $22,786,845      


Agios Pharmaceuticals Inc
 $5,419,090 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $6,556 Denali Therapeutics Inc.
 $445,612 Regeneron Pharmaceuticals Inc
 $292,299 Agios Pharmaceuticals Inc
 $5,419,090 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $6,556 Denali Therapeutics Inc.
 $445,612 Regeneron Pharmaceuticals Inc
 $292,299
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    3    

     Stock price went up :

    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 118.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2024-05-31 21,496 2024-05-31 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    154         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-18 4 OE $0.30 $10,588 D/D 35,000 35,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-10-02 4 OE $0.30 $1,815 D/D 6,000 6,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-10-04 4 OE $0.30 $24,200 D/D 80,000 80,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-11-01 4 OE $0.30 $1,815 D/D 6,000 6,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-12-01 4 OE $0.30 $1,815 D/D 6,000 6,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-16 4 OE $0.30 $16,033 D/D 53,000 53,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-23 4 OE $0.30 $9,945 D/D 32,875 32,875 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-24 4 OE $0.30 $6 D/D 20 20 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-24 4 OE $0.30 $4,094 D/D 13,533 13,533 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-26 4 OE $0.30 $7,131 D/D 23,572 23,572 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-02-01 4 OE $0.30 $3,933 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-03-01 4 OE $0.30 $3,933 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-04-02 4 OE $0.30 $3,933 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-01 4 OE $0.30 $3,933 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-23 4 OE $0.30 $14,936 D/D 49,374 49,374 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-30 4 OE $0.30 $17,675 D/D 45,626 45,626 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-06-01 4 OE $0.47 $6,280 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-09-05 4 OE $2.34 $249,028 D/D 75,119 75,119 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-01-17 4 OE $9.05 $181,000 D/D 20,000 137,879 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-01-30 4 OE $9.05 $181,000 D/D 20,000 137,879 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-02-13 4 OE $9.05 $181,000 D/D 20,000 137,879 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-02-27 4 OE $9.05 $181,000 D/D 20,000 137,879 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-03-27 4 OE $9.05 $181,000 D/D 20,000 137,879 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-04-03 4 OE $9.05 $148,085 D/D 16,363 134,242 0 -
FMI Foundation Medicine, Inc. Director   –       •      –    2016-06-16 4 A $19.93 $240,655 D/D 12,075 23,326 0 -

  154  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed